These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 3580899

  • 1. Dissociation of tolerance and dependence to morphine: a possible role for cholecystokinin.
    Panerai AE, Rovati LC, Cocco E, Sacerdote P, Mantegazza P.
    Brain Res; 1987 Apr 28; 410(1):52-60. PubMed ID: 3580899
    [Abstract] [Full Text] [Related]

  • 2. Spinal co-administration of cholecystokinin antagonists with morphine prevents the development of opioid tolerance.
    Kellstein DE, Mayer DJ.
    Pain; 1991 Nov 28; 47(2):221-229. PubMed ID: 1762818
    [Abstract] [Full Text] [Related]

  • 3. The selective CCK-B receptor antagonist L-365,260 enhances morphine analgesia and prevents morphine tolerance in the rat.
    Dourish CT, O'Neill MF, Coughlan J, Kitchener SJ, Hawley D, Iversen SD.
    Eur J Pharmacol; 1990 Jan 25; 176(1):35-44. PubMed ID: 2311658
    [Abstract] [Full Text] [Related]

  • 4. CI988, a selective antagonist of cholecystokininB receptors, prevents morphine tolerance in the rat.
    Xu XJ, Wiesenfeld-Hallin Z, Hughes J, Horwell DC, Hökfelt T.
    Br J Pharmacol; 1992 Mar 25; 105(3):591-6. PubMed ID: 1628146
    [Abstract] [Full Text] [Related]

  • 5. Chronic administration of cholecystokinin antagonists reverses the enhancement of spinal morphine analgesia induced by acute pretreatment.
    Kellstein DE, Mayer DJ.
    Brain Res; 1990 May 21; 516(2):263-70. PubMed ID: 2364292
    [Abstract] [Full Text] [Related]

  • 6. Potentiation of morphine analgesia by the cholecystokinin antagonist proglumide.
    Watkins LR, Kinscheck IB, Mayer DJ.
    Brain Res; 1985 Feb 18; 327(1-2):169-80. PubMed ID: 3838690
    [Abstract] [Full Text] [Related]

  • 7. Potentiation of systemic morphine analgesia in humans by proglumide, a cholecystokinin antagonist.
    Price DD, von der Gruen A, Miller J, Rafii A, Price C.
    Anesth Analg; 1985 Aug 18; 64(8):801-6. PubMed ID: 4014744
    [Abstract] [Full Text] [Related]

  • 8. Enhancement of morphine analgesia and prevention of morphine tolerance in the rat by the cholecystokinin antagonist L-364,718.
    Dourish CT, Hawley D, Iversen SD.
    Eur J Pharmacol; 1988 Mar 15; 147(3):469-72. PubMed ID: 3378566
    [Abstract] [Full Text] [Related]

  • 9. Proglumide prevents and curtails acute tolerance to morphine in rats.
    Tang J, Chou J, Iadarola M, Yang HY, Costa E.
    Neuropharmacology; 1984 Jun 15; 23(6):715-8. PubMed ID: 6462377
    [Abstract] [Full Text] [Related]

  • 10. The role of CCK caerulein, and CCK antagonists in nociception.
    Baber NS, Dourish CT, Hill DR.
    Pain; 1989 Dec 15; 39(3):307-328. PubMed ID: 2694075
    [Abstract] [Full Text] [Related]

  • 11. Potentiation of opiate analgesia and apparent reversal of morphine tolerance by proglumide.
    Watkins LR, Kinscheck IB, Mayer DJ.
    Science; 1984 Apr 27; 224(4647):395-6. PubMed ID: 6546809
    [Abstract] [Full Text] [Related]

  • 12. Activation of oxytocin neurones by systemic cholecystokinin is unchanged by morphine dependence or withdrawal excitation in the rat.
    Brown CH, Munro G, Murphy NP, Leng G, Russell JA.
    J Physiol; 1996 Nov 01; 496 ( Pt 3)(Pt 3):787-94. PubMed ID: 8930844
    [Abstract] [Full Text] [Related]

  • 13. Spinal antagonism of tolerance and dependence induced by systemically administered morphine.
    Delander GE, Takemori AE.
    Eur J Pharmacol; 1983 Oct 14; 94(1-2):35-42. PubMed ID: 6686142
    [Abstract] [Full Text] [Related]

  • 14. Antagonists of central and peripheral behavioral actions of cholecystokinin octapeptide.
    Crawley JN, Stivers JA, Hommer DW, Skirboll LR, Paul SM.
    J Pharmacol Exp Ther; 1986 Feb 14; 236(2):320-30. PubMed ID: 3003339
    [Abstract] [Full Text] [Related]

  • 15. Cholecystokinin-B receptor antagonists attenuate morphine dependence and withdrawal in rats.
    Lu L, Huang M, Liu Z, Ma L.
    Neuroreport; 2000 Mar 20; 11(4):829-32. PubMed ID: 10757528
    [Abstract] [Full Text] [Related]

  • 16. Extracellular cholecystokinin levels in the rat spinal cord following chronic morphine exposure: an in vivo microdialysis study.
    Lucas GA, Hoffmann O, Alster P, Wiesenfeld-Hallin Z.
    Brain Res; 1999 Mar 06; 821(1):79-86. PubMed ID: 10064790
    [Abstract] [Full Text] [Related]

  • 17. Cholecystokinin antagonists proglumide, lorglumide and benzotript, but not L-364,718, interact with brain opioid binding sites.
    Gaudreau P, Lavigne GJ, Quirion R.
    Neuropeptides; 1990 May 06; 16(1):51-5. PubMed ID: 2174522
    [Abstract] [Full Text] [Related]

  • 18. Peripheral participation of cholecystokinin in the morphine-induced peripheral antinociceptive effect in non-diabetic and diabetic rats.
    Torres-López JE, Juárez-Rojop IE, Granados-Soto V, Diaz-Zagoya JC, Flores-Murrieta FJ, Ortíz-López JU, Cruz-Vera J.
    Neuropharmacology; 2007 Mar 06; 52(3):788-95. PubMed ID: 17157334
    [Abstract] [Full Text] [Related]

  • 19. Effects induced by BC 264, a selective agonist of CCK-B receptors, on morphine-dependent rats.
    Maldonado R, Valverde O, Derrien M, Tejedor-Real P, Roques BP.
    Pharmacol Biochem Behav; 1994 Jun 06; 48(2):363-9. PubMed ID: 8090802
    [Abstract] [Full Text] [Related]

  • 20. Modification of morphine-induced analgesia, tolerance and dependence by bromocriptine.
    Gomaa AA, Mohamed LH, Ahmed HN.
    Eur J Pharmacol; 1989 Nov 07; 170(3):129-35. PubMed ID: 2620694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.